Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Odds Ratio01:09

Odds Ratio

368
The odds ratio (OR) is a statistical measure used extensively in epidemiology and research to quantify the strength of association between exposure and outcome across different groups. Unlike relative risk, which compares the probabilities of an event occurring, the odds ratio compares the odds of an event occurring in the exposed group to the odds of it occurring in the unexposed group. The odds, in this context, are calculated as the probability of the event happening divided by the...
368
Relative Risk01:12

Relative Risk

505
Relative risk (RR) is a statistical measure commonly used in epidemiology to compare the likelihood of a particular event occurring between two groups. This metric is important for evaluating the relationship between exposure to a specific risk factor and the probability of a particular outcome. It plays a crucial role in medical research, public health studies, and risk assessment. Relative risk quantifies how much more (or less) likely an event is to occur in an exposed group compared to an...
505
Testing a Claim about Population Proportion01:24

Testing a Claim about Population Proportion

3.5K
A complete procedure for testing a claim about a population proportion is provided here.
There are two methods of testing a claim about a population proportion: (1) Using the sample proportion from the data where a binomial distribution is approximated to the normal distribution and (2) Using the binomial probabilities calculated from the data.
The first method uses normal distribution as an approximation to the binomial distribution. The requirements are as follows: sample size is large...
3.5K
Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches01:23

Types of Biopharmaceutical Studies: Controlled and Non-Controlled Approaches

197
Biopharmaceutical studies constitute a vital field aiming to enhance drug delivery methods and refine therapeutic approaches, drawing upon diverse interdisciplinary knowledge. In research methodologies, the choice between controlled and non-controlled studies significantly influences the study's reliability and accuracy.
Non-controlled studies, commonly employed for initial exploration, lack a control group, rendering them susceptible to biases and external influences. In contrast,...
197
Comparing the Survival Analysis of Two or More Groups01:20

Comparing the Survival Analysis of Two or More Groups

340
Survival analysis is a cornerstone of medical research, used to evaluate the time until an event of interest occurs, such as death, disease recurrence, or recovery. Unlike standard statistical methods, survival analysis is particularly adept at handling censored data—instances where the event has not occurred for some participants by the end of the study or remains unobserved. To address these unique challenges, specialized techniques like the Kaplan-Meier estimator, log-rank test, and...
340
Assumptions of Survival Analysis01:15

Assumptions of Survival Analysis

217
Survival models analyze the time until one or more events occur, such as death in biological organisms or failure in mechanical systems. These models are widely used across fields like medicine, biology, engineering, and public health to study time-to-event phenomena. To ensure accurate results, survival analysis relies on key assumptions and careful study design.
217

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Patient-Reported Outcomes in Masculinizing Gender-Affirming Chest Surgery: Validation of the GENDER-Q Chest Scales.

The British journal of surgery·2026
Same author

Strike a pose, and…virtual visit? Examining virtual vs. in-person consultations for gender affirmation surgery.

Journal of plastic, reconstructive & aesthetic surgery : JPRAS·2026
Same author

Engineered Lipid Nanoparticles with Promoted Endosomal Escape and R283S-Mediated Stimulator of Interferon Genes (STING) Activation for Pancreatic Cancer Immunotherapy.

Pharmaceutics·2026
Same author

A Refined Rotation Forest-Based Ensemble Classifier for Lithological Mapping with ZY1-02D Hyperspectral Remote Sensing Imagery.

Sensors (Basel, Switzerland)·2026
Same author

Dual-responsive polypyridyl Ru(II)-scaffolded hydrogel for trinitarian tumor therapy activated by mono-wavelength photo-irradiation.

Journal of nanobiotechnology·2026
Same author

A viral protein-driven ubiquitination switch fine-tunes chloroplast outer envelope protein homeostasis.

The Plant cell·2026

Related Experiment Video

Updated: Oct 13, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K

Calling small variants using universality with Bayes-factor-adjusted odds ratios.

Xiaofei Zhao1, Allison C Hu1, Sizhen Wang1

  • 1Genetron Health (Beijing) Co. Ltd, Beijing 102208, China.

Briefings in Bioinformatics
|November 18, 2021
PubMed
Summary
This summary is machine-generated.

UVC is a novel variant calling method that improves accuracy in next-generation sequencing. It uses two empirical laws to enhance precision for germline and somatic variants in clinical settings.

Keywords:
applied statisticsbioinformaticsclinical applicationsnext-generation sequencingpower lawsoftware

More Related Videos

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K

Related Experiment Videos

Last Updated: Oct 13, 2025

An R-Based Landscape Validation of a Competing Risk Model
05:37

An R-Based Landscape Validation of a Competing Risk Model

Published on: September 16, 2022

2.2K
Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry
05:53

Candidate Gene Testing in Clinical Cohort Studies with Multiplexed Genotyping and Mass Spectrometry

Published on: June 21, 2018

10.3K
Establishing a Competing Risk Regression Nomogram Model for Survival Data
04:57

Establishing a Competing Risk Regression Nomogram Model for Survival Data

Published on: October 23, 2020

10.4K

Area of Science:

  • Genomics
  • Bioinformatics
  • Clinical Diagnostics

Background:

  • Accurate variant calling is crucial for next-generation sequencing (NGS) applications in research and clinical settings.
  • Existing variant callers face challenges with accuracy, especially for germline and somatic variants.
  • The need for robust and precise methods is paramount for reliable genomic data interpretation.

Purpose of the Study:

  • To introduce UVC, a new method for highly accurate small variant calling of germline or somatic origin.
  • To establish two empirical laws that significantly improve variant calling performance.
  • To demonstrate UVC's superior performance compared to existing variant callers.

Main Methods:

  • UVC unifies opposing assumptions using a technique called sublation.
  • Developed two empirical laws: inverse proportionality between allele fraction and cubic root of error rate at high depth, and modeling biases with odds ratios and Bayes factors.
  • Evaluated UVC on diverse datasets including GIAB germline and somatic truth sets, in silico mixtures, SEQC2 somatic reference sets, and a clinical gene panel dataset.

Main Results:

  • UVC demonstrated superior performance across various truth sets and simulated scenarios.
  • Achieved 100% concordance with manual review on a clinical gene panel dataset.
  • Outperformed other unique molecular identifier (UMI)-aware variant callers, providing new insights into DNA damage repair.

Conclusions:

  • UVC significantly enhances the accuracy of small variant calling for both germline and somatic mutations.
  • The method's performance is validated across multiple benchmark datasets and clinical applications.
  • UVC offers a robust solution for accurate variant detection in NGS, with open-source availability.